“Ozempic faces over $2 bn lawsuits

What’s Going On?

• The lawsuits are real: There is indeed a multidistrict litigation (MDL No. 3094) underway, consolidating thousands of cases against Novo Nordisk (maker of Ozempic, Wegovy, Rybelsus) and others like Eli Lilly for Mounjaro. The first lawsuit was filed in August 2023, and by early August 2025 there were over 1,800 lawsuits in the Eastern District of Pennsylvania.Business Standard+1Goza & Honnold+5King Law+5Melinda J. Helbock, A.P.C. San Diego+5
• The $2 billion figure is speculative: Analysts estimate that total liability could exceed $2 billion, but there’s no public documentation or court ruling confirming that exact number. It’s based on projection, not settled verdicts.SnopesMelinda J. Helbock, A.P.C. San DiegoMedPathBusiness Standard
• Plaintiffs’ claims include:
  • Gastroparesis (stomach paralysis)
  • Intestinal blockages
  • Gallbladder issues
  • Vision loss (NAION)
  • Pancreatitis, kidney problems, and moreThe Wall Street Journal+15King Law+15TruLaw+15
• Media reports reflect rising litigation concerns: For instance:
  • Business Standard states Ozempic is facing over $2 bn in lawsuits as patients allege severe outcomes like stomach paralysis and vision loss.Fierce Pharma+7Business Standard+7MedPath+7
  • MedPath similarly reports 1,800+ lawsuits and potential liability above $2 billion.MedPath

---

So What’s True—and What’s Unclear?

Claim	Status
Lawsuits exist and are growing	True—over 1,800 cases are consolidated in MDL No. 3094.9news.comKing Law+3Melinda J. Helbock, A.P.C. San Diego+3MedPath+3
Total liability exceeding $2 billion	Possible but unconfirmed—based on analysts’ estimates; no final figure yet.SnopesMelinda J. Helbock, A.P.C. San DiegoMedPathBusiness Standard

---

What Should You Know?

• The MDL is actively progressing, with discovery and pretrial stages underway. Bellwether trials are expected to start in early 2026.MedPath+1
• Courts and legal professionals are reviewing medical test requirements—for example, a judge dictated that plaintiffs claiming gastroparesis must submit gastric emptying test results.Slepkow Law+10King Law+10lawsuit-information-center.com+10
• Corporate strategy: Novo Nordisk continues to face not only these lawsuits but also legal actions against compounding pharmacies selling Ozempic/Wegovy knockoffs.TruLaw+15Reuters+15King Law+15
• Business impact: Novo Nordisk’s growth is cooling due to competition and regulatory pressures, sparking investor concerns and contributing to litigation interest.